Skip to main content
OpenTrials

Clinical trial condition

Recurrent Cancer

Explore clinical trials studying Recurrent Cancer. Study availability and eligibility vary by location and protocol.

26 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Cancer trial results

Active, not recruiting

IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor

NCT05359445

Conditions
Cancer, Disease Attributes, Neoplasms, +6 more
Locations
  • Universitaetsklinikum Freiburg, Zentralklinikum, Klinik fuer Innere Medizin I Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Universitaetsklinikum Heidelberg AöR, Nationales Zentrum fuer Tumorkrankheiten Heidelberg, Baden-Wurttemberg, Germany
  • Thoraxklinik Heidelberg gGmbH, Studienzentrum Thoraxonkologie Heidelberg, Baden-Wurttemberg, Germany
  • Universitaetsklinikum Tuebingen AöR, Comprehensive Cancer Center Tuebingen Tübingen, Baden-Wurttemberg, Germany
View all 21 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma

NCT05043922

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +18 more
Locations
  • Beijing Obstetrics and Gynecology Hospital, Capital Medical University Beijing, China
  • Chinese PLA General Hospital Beijing, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, China
  • The Southwest Hospital of AMU Chongqing, China
View all 36 locations
View Trial Details
Completed

Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling

NCT03760952

Conditions
Adult Solid Tumor, Disease Attributes, Neoplasm Metastasis, +7 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Columbia University Medical Center New York, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
  • Oncology Consultants Houston, Texas, United States
View Trial Details
Completed

TCR-engineered T Cells in Solid Tumors: IMA202-101

NCT03441100

Conditions
Cancer, Disease Attributes, Neoplasms, +6 more
Locations
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Universitätsklinikum Würzburg Würzburg, Bavaria, Germany
  • Universitätsklinikum Bonn - Medizinische Klinik III Bonn, North Rhine-Westphalia, Germany
View Trial Details
Completed

Recurrence After Whipple's (RAW) Study

NCT04596865

Conditions
Adenocarcinoma, Ampullary Cancer, Bile Duct Cancer, +35 more
Locations
  • Monash Medical Centre Clayton, Victoria, Australia
  • Medical University Innsbruck, Anichstr. 35 A Innsbruck, Austria
  • Azienda Ospedaliero - Universitaria Di Sassari Sassari, Sardinia, Italy
  • Azienda Ospedaliero - Universitaria Policlinico Umberto I Rome, Italy
View all 29 locations
View Trial Details

Related conditions